Search results
‘Unusual’ cancers emerged after the pandemic. Doctors ask if COVID is to blame.
Anchorage Daily News· 1 day agoKashyap Patel looked forward to his team’s Friday lunches. It was 2021, a year into the coronavirus...
LGBTQ+ population faces greater cancer risks. Also faces barriers to care, studies show.
USA TODAY via Yahoo News· 5 days agoCorrection: This story was updated to reflect that hepatitis B vaccinations were higher among LGBTQ+ people than heterosexual adults. LGBTQ+ people are more likely to face ...
Investors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know
Zacks via Yahoo Finance· 2 days agoSo, it might be a good idea to review some of the factors that might affect the near-term...
Biotech Stock Roundup: GSK's Litigation Update, BIIB's Drug Approval & Other Updates
Zacks via Yahoo Finance· 2 days agoThe study is evaluating the safety, tolerability and efficacy of tobevibart and investigational...
GSK, after 11-month romance, buys oligonucleotide partner Elsie for up to $50M
FierceBiotech· 2 days agoAfter taking 11 months to get to know Elsie Biotechnologies' oligonucleotide platform, GSK is ready...
Fecal Transplants Are Going Viral As Potential Depression And IBS Relief, Here Is What Experts Say...
BuzzFeed via Yahoo News· 1 day agoBoth doctors also said it is important to note that when fecal transplants are performed in medical...
Magistrate Sides With Defendants in Inmate's Claims in Failure to Treat Hep C | Law.com
Law.com· 5 days agoIn a memorandum opinion and recommendation issued May 28, Auld found that physician assistant Karen...
Funnels and fun: Helen Hunt shares memories from her 'Twister' experiences
Tulsa World· 2 days agoHelen Hunt, for instance, endured hepatitis shots, vision impairment and a concussion. Hunt and Bill...
How A New Covid-19 Antibody Could Contribute To Advanced Vaccine Development
Forbes· 2 days agoIn the ongoing Omicron era, a new Covid-19 antibody could renew optimism for urgently required...
Atea Pharmaceuticals Shares Promising Data From Therapy Study For Hepatitis C Virus - Atea...
Benzinga· 3 days agoAtea Pharmaceuticals Inc AVIR announced Wednesday new data from the lead-in cohort (n=60) of the company’s ongoing Phase 2 combination study of bemnifosbuvir for hepatitis ...